Shaat Nael, Ignell Claes, Katsarou Anastasia, Berntorp Kerstin
Department of Clinical Sciences, Lund University, Malmö, Sweden.
Department of Endocrinology, Skåne University Hospital, Malmö, Sweden.
Acta Obstet Gynecol Scand. 2017 Jul;96(7):821-827. doi: 10.1111/aogs.13124. Epub 2017 Apr 10.
We wanted to determine vitamin D status after gestational diabetes mellitus (GDM) and to evaluate whether levels of 25-hydroxyvitamin D (25OHD ) are associated with beta cell function, insulin resistance or a diagnosis of diabetes after GDM.
Glucose homeostasis was assessed during a 75-g oral glucose tolerance test one to two years after delivery in 376 women with previous GDM (287 European and 78 non-European, including 33 Arab and 35 Asian women). Insulin resistance was estimated using homeostasis model assessment of insulin resistance (HOMA-IR). The insulinogenic index (I/G30) and the disposition index [(I/G30)/HOMA-IR] were used to calculate insulin secretion. Concentrations of serum 25OHD were determined.
Mean (±SD) 25OHD concentration was 50.0 ± 22.3 nmol/L and differed significantly among subgroups of body mass index, ethnicity, and glucose tolerance status; 53% had 25OHD levels <50 nmol/L and 87% had 25OHD levels <75 nmol/L. There was a negative correlation between 25OHD concentration and HOMA-IR (p < 0.001) and a positive correlation between 25OHD and disposition index (p = 0.002) in univariable regression analysis. Correlations attenuated after adjustment for body mass index. In univariable regression analysis, 25OHD concentrations were significantly associated with diabetes after GDM (p = 0.004). However, in a multivariable model, non-European origin, HOMA-IR and insulinogenic index were significantly associated with postpartum diabetes, whereas 25OHD concentrations were not.
Vitamin D deficiency/insufficiency in previous GDM cases appears to be associated with beta cell dysfunction and insulin resistance, but not with postpartum diabetes when factors well known to influence type-2 diabetes were adjusted for.
我们想要确定妊娠糖尿病(GDM)后的维生素D状态,并评估25-羟维生素D(25OHD)水平是否与β细胞功能、胰岛素抵抗或GDM后的糖尿病诊断相关。
对376例既往有GDM的女性(287例欧洲女性和78例非欧洲女性,包括33例阿拉伯女性和35例亚洲女性)在分娩后1至2年进行75克口服葡萄糖耐量试验,评估葡萄糖稳态。使用胰岛素抵抗稳态模型评估(HOMA-IR)估计胰岛素抵抗。胰岛素生成指数(I/G30)和处置指数[(I/G30)/HOMA-IR]用于计算胰岛素分泌。测定血清25OHD浓度。
25OHD平均(±标准差)浓度为50.0±22.3nmol/L,在体重指数、种族和糖耐量状态亚组之间存在显著差异;53%的患者25OHD水平<50nmol/L,87%的患者25OHD水平<75nmol/L。在单变量回归分析中,25OHD浓度与HOMA-IR呈负相关(p<0.001),与处置指数呈正相关(p=0.002)。调整体重指数后相关性减弱。在单变量回归分析中,25OHD浓度与GDM后的糖尿病显著相关(p=0.004)。然而,在多变量模型中,非欧洲血统、HOMA-IR和胰岛素生成指数与产后糖尿病显著相关,而25OHD浓度则无相关性。
既往GDM患者的维生素D缺乏/不足似乎与β细胞功能障碍和胰岛素抵抗有关,但在对影响2型糖尿病的已知因素进行调整后,与产后糖尿病无关。